---
title: "After the earnings report, PA GOODDOCTOR faced pressure, dropping over 9% at one point"
description: "After announcing its performance for the first nine months, PA GOODDOCTOR's stock price once fell by more than 9%, currently reported at 14.47 yuan, down 6.52%. The company's revenue for the first thr"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262530436.md"
published_at: "2025-10-24T02:05:58.000Z"
---

# After the earnings report, PA GOODDOCTOR faced pressure, dropping over 9% at one point

> After announcing its performance for the first nine months, PA GOODDOCTOR's stock price once fell by more than 9%, currently reported at 14.47 yuan, down 6.52%. The company's revenue for the first three quarters increased by 13.6% year-on-year to 3.725 billion yuan, with a net profit of 184 million yuan, an increase of 72.6%. Morgan Stanley pointed out that the slowdown in growth in the third quarter was affected by deteriorating fundamentals and seasonal factors

PA GOODDOCTOR (01833.HK) faced pressure on its stock price after announcing its performance for the first nine months. Today (24th), it opened high at 1.74% but then turned around and fell, at one point dropping 9.4%. It is currently reported at HKD 14.47, down 6.52%, with a trading volume of 13.4998 million shares, involving HKD 195 million.

PA GOODDOCTOR announced after the market closed yesterday that its revenue for the first three quarters of this year increased by 13.6% year-on-year to RMB 3.725 billion (the same below). The net profit was RMB 184 million, an increase of 72.6% year-on-year; the adjusted net profit was RMB 216 million, up 45.7% year-on-year. Morgan Stanley pointed out that PA GOODDOCTOR's growth slowed in the third quarter of this year due to deteriorating fundamentals and seasonal factors.

PA GOODDOCTOR announced its interim results for the year in mid-August, reporting a turnover of RMB 2.502 billion, an increase of 19.5% year-on-year, and a net profit of RMB 134 million, up 136.8% year-on-year; earnings per share were 7 cents

### Related Stocks

- [01833.HK - PA GOODDOCTOR](https://longbridge.com/en/quote/01833.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 花旗银行继续给予平安健康医疗科技公司（PANHF）买入评级 | 在今天发布的一份报告中，花旗维持了对中国平安医疗科技公司的买入评级，目标价为 18.00 港元。中国平安医疗科技公司获得了分析师一致的强烈买入评级，目标价共识为 19.45 港元 | [Link](https://longbridge.com/en/news/274969599.md) |
| 渣打银行首次为本地公司设 ESG 挂钩现金账户 客户为数据中心运营商 STT GDC \| 联合早报网 | 新加坡渣打银行首次为新科电信媒体全球数据中心公司（STT GDC）设立与环境、社会和治理（ESG）挂钩的现金账户。这是该银行在本区域注册公司设立的第一个此类账户，旨在将可持续发展绩效与现金余额回报挂钩，奖励客户在实现 ESG 目标方面的进展 | [Link](https://longbridge.com/en/news/276324760.md) |
| 领土问题首上谈判桌 俄乌博弈进入 “深水区” | 在日内瓦举行的俄美乌三方谈判中，领土问题首次被纳入讨论议程。谈判于 2 月 17 日至 18 日进行，俄方称谈判 “务实高效”，乌方表示讨论深入且具有实质意义，美方则称各方同意继续谈判。尽管各方均表示取得进展，但关于下一轮谈判的细节尚未公布 | [Link](https://longbridge.com/en/news/276289464.md) |
| 华尔街大佬 Tepper 押注 AI：美光持仓激增 200%，新买韩国 ETF | 对冲基金大佬 Tepper 去年四季度精准狙击 AI 芯片赛道，豪掷逾 6 亿美元重仓美光科技和韩国芯片 ETF，今年已斩获约 30% 回报。全球内存短缺叠加 AI 算力狂潮，其芯片押注与软件股暴跌形成冰火两重天。 | [Link](https://longbridge.com/en/news/276213747.md) |
| Select 医药控股｜10-K：2025 财年营收 54.53 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276384073.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.